Neuropathic Pain Clinical Trial
Official title:
Effectiveness of Neural Mobilizations Exercises Versus Surgery in Patients With Carpal Tunnel Syndrome
neural exercise in patients with carpal tunnel syndrome
OBJECTIVE: The aim objective is to compare the neurophysiological effects of the surgery
versus neural mobilization exercises added to surgery versus only neural mobilization
exercises on temporal summation and noxious inhibitory pain system and their relationship
with the improve of symptoms, with pain and disability in patients with Carpal tunnel
syndrome.
STUDY DESIGN: Randomized parallel-group trial. BACKGROUND: Carpal tunnel syndrome (CTS) such
as a neuropathic pain condition with altered pain modulation and wind-up, but there is a
clack of knowledge if some therapies could have a positive effect.
METHODS: In the Humans study, 54 patients with CTS will be randomly allocated to either a
surgery group (n=18) or Surgery with neural exercises group (n=18) or neural exercise group
(n=18), the groups with neural exercise will received 10 sessions. The primary outcome will
be conditioned pain modulation, temporal summation, pain intensity,. Secondary outcomes will
be hand disability assessed with the Boston Carpal Tunnel Questionnaire, pinch-tip grip
force, and the symptom severity subscale of the Boston Carpal Tunnel Questionnaire,
neuropathic pain questionnaire (DN4), psychological questionnaires (anxiety, catastrophizing,
kinesiophobia depression and fear avoid questionnaires), and pressure pain threshold.
Patients will be assessed baseline and post-treatment, 1, 3 and 6 months after the last
treatment by an assessor unaware of group assignment Patients were assessed at. Analysis was
by intention to treat, with mixed analyses of covariance adjusted for baseline scores.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04699734 -
Peripheral Nerve Block in Patients With Painful Diabetic Polyneuropathy
|
N/A | |
Recruiting |
NCT06019325 -
Rhomboid Intercostal Plane Block on Chronic Pain Incidence and Acute Pain Scores After Mastectomy
|
N/A | |
Completed |
NCT05235191 -
Effectiveness and Safety of Methadone Versus Placebo for the Control of Neuropathic Pain in Different Etiologies
|
Phase 3 | |
Completed |
NCT05845177 -
Persistent Pain After Hip Replacement
|
||
Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
Not yet recruiting |
NCT05949554 -
Electroencephalographic (EEG) Profils for Patients on Intravenous Ketamine.
|
||
Withdrawn |
NCT05052645 -
Ear Acupuncture for Neuropathic Pain
|
N/A | |
Completed |
NCT02866396 -
Impact of Pregabalin in Chronic Users vs. a Perioperative Limited Prescription on Oxycodone Requirement
|
||
Completed |
NCT02930551 -
Neuromas as the Cause of Pain
|
N/A | |
Completed |
NCT02824588 -
Working Memory Training for Chronic Neuropathic and Fibromyalgia Pain
|
N/A | |
Active, not recruiting |
NCT02560545 -
Cannabinoids Effects on the Pain Modulation System
|
N/A | |
Enrolling by invitation |
NCT02485795 -
Observational Study of the Impact of Genetic Testing on Healthcare Decisions and Care in Interventional Pain Management
|
N/A | |
Completed |
NCT02099890 -
The Effect of Diet on Chronic Inflammation and Related Disorders Following Spinal Cord Injury
|
Phase 3 | |
Not yet recruiting |
NCT02246517 -
The Effect of N2O on Chronic Neuropathic Pain Patients
|
Phase 0 | |
Completed |
NCT01946555 -
Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain
|
N/A | |
Completed |
NCT01718821 -
Assessments on Current Pain Managements in Upper Gastrointestinal Cancer Patients
|
N/A | |
Completed |
NCT01884662 -
Virtual Walking for Neuropathic Pain in Spinal Cord Injury
|
N/A | |
Completed |
NCT01669967 -
The Role of Intravenous (IV) Lidocaine in the Management of Chronic Neuropathic Pain of Peripheral Nerve Origin
|
N/A | |
Completed |
NCT01201317 -
A Study to Investigate the Analgesic Efficacy of AZD2423 Compared With Placebo After 28 Days Treatment in Patients With Painful Diabetic Polyneuropathy
|
Phase 2 | |
Completed |
NCT01207596 -
Evaluating the Efficacy and Safety of Extended Release Hydromorphone (Exalgo) in Patients With Neuropathic Pain
|
Phase 4 |